|
1
|
Samsara BioCapital
Palo Alto,
California
|
$28.8M
|
–
|
–
|
–
|
|
|
2
|
Caligan Partners
New York
|
$27.6M
|
+$18.1M
|
+2,974,906
|
+149%
|
|
|
3
|
Paradigm Biocapital Advisors
New York
|
$22.2M
|
–
|
–
|
–
|
|
|
4
|
Millennium Management
New York
|
$16.6M
|
+$2.04M
|
+335,043
|
+13%
|
|
|
5
|
Trails Edge Capital Partners
Atlanta,
Georgia
|
$14.8M
|
–
|
–
|
–
|
|
|
6
|
Franklin Resources
San Mateo,
California
|
$13.7M
|
-$235K
|
-38,576
|
-2%
|
|
|
7
|
SymBiosis Capital Partners
Bentonville,
Arkansas
|
$13.1M
|
-$1.5M
|
-246,000
|
-9%
|
|
|
8
|
UBS Group
Zurich,
Switzerland
|
$12.9M
|
-$1.98M
|
-325,009
|
-12%
|
|
|
9
|
ADAR1 Capital Management
Austin,
Texas
|
$12.1M
|
-$3.26M
|
-535,448
|
-20%
|
|
|
10
|
Polar Capital Holdings
London,
United Kingdom
|
$11.8M
|
+$812K
|
+133,258
|
+7%
|
|
|
11
|
|
$10.1M
|
–
|
–
|
–
|
|
|
12
|
|
$8.32M
|
–
|
–
|
–
|
|
|
13
|
Boothbay Fund Management
New York
|
$8.16M
|
+$4.95M
|
+811,436
|
+123%
|
|
|
14
|
NEA Management Company
Timonium,
Maryland
|
$8.03M
|
–
|
–
|
–
|
|
|
15
|
Ikarian Capital
Dallas,
Texas
|
$7.84M
|
+$5.65M
|
+926,500
|
+184%
|
|
|
16
|
NEXTBio Capital Management
Menlo Park,
California
|
$7.4M
|
+$212K
|
+34,783
|
+3%
|
|
|
17
|
|
$7.21M
|
+$6
|
+1
|
+0%
|
|
|
18
|
Deep Track Capital
Greenwich,
Connecticut
|
$6.78M
|
+$4.47M
|
+732,453
|
+149%
|
|
|
19
|
Point72 Asset Management
Stamford,
Connecticut
|
$5.31M
|
+$5.83M
|
+956,221
|
New
|
|
|
20
|
Ameriprise
Minneapolis,
Minnesota
|
$4.69M
|
+$1.39M
|
+228,742
|
+37%
|
|
|
21
|
Ally Bridge Group
New York
|
$4.14M
|
-$4.6M
|
-754,700
|
-50%
|
|
|
22
|
Propel Bio Management
Los Angeles,
California
|
$3.99M
|
-$1.68M
|
-275,322
|
-28%
|
|
|
23
|
BVF Inc
San Francisco,
California
|
$3.81M
|
–
|
–
|
–
|
|
|
24
|
Marshall Wace
London,
United Kingdom
|
$3.63M
|
+$2.94M
|
+482,118
|
+280%
|
|
|
25
|
HighVista Strategies
Boston,
Massachusetts
|
$3.42M
|
+$3.75M
|
+615,666
|
New
|
|
